LVW Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Sell |
712
-179
| -20% | -$72.6K | 0.03% | 266 |
|
|
2025
Q1 | $443K | Buy |
891
+2
| +0.2% | +$995 | 0.05% | 189 |
|
|
2024
Q4 | $462K | Sell |
889
-21
| -2% | -$10.9K | 0.06% | 198 |
|
|
2024
Q3 | $563K | Sell |
910
-43
| -5% | -$26.6K | 0.07% | 175 |
|
|
2024
Q2 | $527K | Buy |
953
+4
| +0.4% | +$2.21K | 0.08% | 160 |
|
|
2024
Q1 | $552K | Sell |
949
-56
| -6% | -$32.5K | 0.09% | 156 |
|
|
2023
Q4 | $533K | Buy |
1,005
+150
| +18% | +$79.6K | 0.1% | 144 |
|
|
2023
Q3 | $433K | Sell |
855
-16
| -2% | -$8.1K | 0.09% | 138 |
|
|
2023
Q2 | $454K | Sell |
871
-23
| -3% | -$12K | 0.09% | 131 |
|
|
2023
Q1 | $515K | Sell |
894
-12
| -1% | -$6.92K | 0.1% | 138 |
|
|
2022
Q4 | $499K | Sell |
906
-29
| -3% | -$16K | 0.1% | 144 |
|
|
2022
Q3 | $474K | Buy |
935
+21
| +2% | +$10.6K | 0.11% | 136 |
|
|
2022
Q2 | $497K | Buy |
914
+71
| +8% | +$38.6K | 0.1% | 136 |
|
|
2022
Q1 | $498K | Buy |
843
+24
| +3% | +$14.2K | 0.08% | 144 |
|
|
2021
Q4 | $546K | Sell |
819
-532
| -39% | -$355K | 0.09% | 143 |
|
|
2021
Q3 | $772K | Sell |
1,351
-48
| -3% | -$27.4K | 0.13% | 114 |
|
|
2021
Q2 | $706K | Buy |
1,399
+34
| +2% | +$17.2K | 0.13% | 117 |
|
|
2021
Q1 | $623K | Buy |
1,365
+188
| +16% | +$85.8K | 0.12% | 125 |
|
|
2020
Q4 | $548K | Buy |
1,177
+555
| +89% | +$258K | 0.11% | 110 |
|
|
2020
Q3 | $275K | Sell |
622
-398
| -39% | -$176K | 0.06% | 159 |
|
|
2020
Q2 | $370K | Buy |
+1,020
| New | +$370K | 0.09% | 116 |
|